Fitch Places Thermo Fisher, Life Tech Ratings on Negative Watch after Announcement of $13.6B Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Fitch Ratings placed the ratings of Thermo Fisher Scientific and Life Technologies on Rating Watch Negative following Thermo Fisher's announcement on Monday that it plans to buy Life Tech for $13.6 million.

Thermo Fisher's ratings that were placed on Rating Watch Negative include the company's long-term issuer default rating, which is rated BBB+; short-term IDR, rated F2; senior notes, rated BBB+; and commercial paper, rated F2.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.